<?xml version="1.0" encoding="UTF-8"?>
<p>As the species most frequently and significantly affected by WNV infections aside from birds and humans, horses have been used in pathogenesis work and in efficacy and safety studies required for approval of WNV equine vaccines [
 <xref rid="B191-pathogens-09-00048" ref-type="bibr">191</xref>,
 <xref rid="B192-pathogens-09-00048" ref-type="bibr">192</xref>,
 <xref rid="B193-pathogens-09-00048" ref-type="bibr">193</xref>,
 <xref rid="B194-pathogens-09-00048" ref-type="bibr">194</xref>,
 <xref rid="B195-pathogens-09-00048" ref-type="bibr">195</xref>,
 <xref rid="B196-pathogens-09-00048" ref-type="bibr">196</xref>]. There are currently four United States Department of Agriculture-licensed equine WNV vaccines available in the United States [
 <xref rid="B197-pathogens-09-00048" ref-type="bibr">197</xref>]. 
</p>
